Post by
folknutboy on Aug 02, 2016 10:18pm
blackout
the shorts and naysayers have the advantage and they know it so they are pressing
the company is in a blackout period prior to news so they can't say anything, kind of like getting in a scrap with both hands tied behind your back
the strategic review continues but management don't want to sell because they really want to proceed with their plans- roll out of 60 new products, deleveraging etc
donnatal is not going to be banned and neither are any of the other legacy drugs they sell
the short and distort crowd can say whatever they want and do not get taken to task for it
cohodes even pens a letter to the securities commission whinning about being sued
the short thesis is based on distortion and innuendo
his stock is very undervalued
hopefully the chickens will come home to roost
Comment by
intothewest1982 on Aug 02, 2016 10:32pm
That is simply not true. The company under a normal course issuer bid or employees/mgmt are only restricted from buying stock in this period. The board/mgmt is not restricted from issuing material news if there is any.
Comment by
ItsADonut on Aug 02, 2016 10:43pm
This post has been removed in accordance with Community Policy
Comment by
Lumberfeverlong on Aug 02, 2016 11:09pm
The he point is that if there were something material to be disclosed, good or bad, the company would have an obligation to disclose. Guidance was reaffirmed just few weeks ago. Conclusion is that there is nothing good or bad going on with the company.